Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania

JAMA: The Journal of the American Medical Association

Volumn 271, Issue 12, 1994, Pages 918-924

  Bowden, Charles L ^a   Brugger, Andrew M ^a   Swann, Alan C ^a   Calabrese, Joseph R ^a   Janicak, Philip G ^a   Petty, Frederick ^a   Dilsaver, Steven C ^a   Davis, John M ^a   Rush, A John ^a   Small, Joyce G ^a   Garza Treviño, Enrique S ^a   Risch, S Craig ^a   Goodnick, Paul J ^a   Morris, David D ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; LITHIUM CARBONATE; NEUROLEPTIC AGENT; PLACEBO; VALPROATE SEMISODIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MULTICENTER STUDY; MUSCLE DISEASE; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; THROMBOCYTOPENIA; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALIZATION; HUMANS; LITHIUM; MALE; MIDDLE AGED; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0028281080     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1994.03510360044034     Document Type: Article

References (45)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
2. Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce ML. Affective disorders in five United States communities. Psychol Med. 1988; 18:141-153.
3. Egeland JA. Bipolarity: the iceberg of affective disorders? Compr Psychiatry. 1983;24:337-344.
4. Altman EG, Janicak PG, Davis JM. Mania: clinical manifestations and assessment. In: Howells JG, ed. Modern Perspectives in the Psychiatry of the Affective Disorders. New York, NY: Brunner/Mazel Inc; 1989:292-302.
5. Gershon ES. Genetics. In: Goodwin FK, Jamison KR, eds. Manic-Depressive Illness. New York, NY: Oxford University Press Inc; 1990:369-399.
6. Krauthammer C, Klerman GL. Secondary mania: manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry. 1978;35:1333-1339.
7. Bowden CL, Sarabia F. Diagnosing manic-depressive illness in adolescents. Compr Psychiatry. 1980;21:263-269.
8. Ryan N, Puig-Antich J. Affective illness in adolescence. In: Halls RE, Frances AJ, eds. APA Annual Review. Washington, DC: American Psychiatric Press; 1986;5:420-450.
9. Weissman MM, Bruce ML, Leaf PJ, Florio LP, Holzer C. Affective disorders. In: Robins LN, Regier DA, eds. Psychiatric Disorders in America. New York, NY: Free Press; 1990:53-80.
10. Mirin SM, Weiss RD, Griffin ML, Michael JL. Psychopathology in drug abusers and their families. Compr Psychiatry. 1991;32:36-51.
11. Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988;45:1023-1031.
12. Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. Long-term lithium and mortality. Lancet. 1990;335:1347.
13. SchouM, Juel-Nielsen N, Strömgren E, Voldby H. The treatment of manic psychoses by the administration of lithium salts. J Neurol Neurosurg Psychiatry. 1954;17:250-260.
14. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990:22-25, 36-40, 45-49.
15. Maj M, Pirozzi R, Kemali D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology. 1989;98:535-538.
16. Harrow M, Goldberg JF, Grossman LS, Meltzer HY. Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry. 1990;47:665-671.
17. Tohen M, Waternaux CM, Tsuang MT, Hunt AT. Four-year follow-up of twenty-four first-episode manic patients. J Affect Disord. 1990;19:79-86.
18. Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med. 1989; 321:1489-1493.
19. Stokes PE, Stoll PM, Shamoian CA, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet. 1971;1:1319-1325.
20. Maggs R. Treatment of manic illness with lithium carbonate. Br J Psychiatry. 1963;109:56-65.
21. Goodwin FK, Murphy DL, Bunney WE. Lithium-carbonate treatment in depression and mania. Arch Gen Psychiatry. 1969;21:486-496.
22. Emrich HM, von Zerssen D, Kissling W, Muller H-J, Windorfer A. Effect of sodium valproate on mania: the GABA-hypothesis of affective disorder. Arch Psychiatr Nervenkr. 1980;229:1-16.
23. Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry. 1990;147:431-434.
24. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992;149:108-111.
25. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania: a placebo-controlled study. Arch Gen Psychiatry. 1991;48:62-68.
26. Van Elteren PH. On the combination of independent two-sample tests of Wilcoxon. Bull Inst Intern Statist. 1960;37:351-361.
27. Spitzer RL, Endicott J, Robbins E. Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders. 2nd ed. New York, NY: New York State Psychiatric Institute; 1975.
28. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
29. Endicott V, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35:837-848.
30. Secunda SK, Katz MM, Swann A, et al. Mania, diagnosis, state measurement and prediction of treatment response. J Affect Disord. 1985;8:113-121.
31. Swann AC, Secunda SK, Katz MM, et al. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res. 1986;18:127-141.
32. SAS User's Guide: Statistics, Version 6 Edition. Cary, NC: SAS Institute Inc; 1991.
33. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in r × c contingency tables. J Am Stat Assoc. 1983;78:427-434.
34. COSTART: Coding Symbols for Thesaurus of Adverse Reaction Terms. 3rd ed. Rockville, Md: Dept of Health and Human Services, Food and Drug Administration, Center for Drugs and Biologics, Division of Drug and Biological Product Experience; 1989.
35. Janicak PG, Sharma RP, Easton M, Cornaty JE, Davis JM. A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania. Psychopharmacol Bull. 1989;25:243-245.
36. Small JG, Klapper MH, Milstein V, et al. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiatry. 1991;48:915-921.
37. Lerer B, Moore N, Meyendorff E, Cho SR, Gerson S. Carbamazepine versus lithium in mania: a double-blind study. J Clin Psychiatry. 1987;48: 89-93.
38. Wilder BJ, Karas BJ, Penry JK, Asconape J. Gastrointestinal tolerance of divalproex sodium. Neurology. 1983;33:808-811.
39. Prien RF, Potter WZ. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull. 1990;26:409-427.
40. Prien RF. NIH report: five-center study clarifies use of lithium, imipramine for recurrent affective disorders. Hosp Community Psychiatry. 1984; 35:1097-1098.
41. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive therapy compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988;45:727-732.
42. Kukopulos A, Reginaldi D, Laddumada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatments. Neuropsychopharmacology. 1980;13:156-167.
43. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull. 1986;22:613-620.
44. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA. 1986; 255:3138-3142.
45. Post RM. Introduction: emerging perspectives on valproate in affective disorders. J Clin Psychiatry. 1989;50(suppl 3):3-9.